These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9743841)

  • 21. Risperidone in the management of agitation and aggression associated with psychiatric disorders.
    De Deyn PP; Buitelaar J
    Eur Psychiatry; 2006 Jan; 21(1):21-8. PubMed ID: 16414250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liquid risperidone in the treatment of psychotic agitation.
    Tsai C; Puzantian T
    CNS Drugs; 2002; 16(11):777; author reply 778. PubMed ID: 12383033
    [No Abstract]   [Full Text] [Related]  

  • 23. [Longterm treatment with Risperidone in Alzheimer's disease? No justification for more "drug deaths" in nursing homes!].
    Förstl H
    Dtsch Med Wochenschr; 2013 Jan; 138(1-2):16. PubMed ID: 23250689
    [No Abstract]   [Full Text] [Related]  

  • 24. Galantamine versus risperidone treatment of neuropsychiatric symptoms in patients with probable dementia: an open randomized trial.
    Freund-Levi Y; Jedenius E; Tysen-Bäckström AC; Lärksäter M; Wahlund LO; Eriksdotter M
    Am J Geriatr Psychiatry; 2014 Apr; 22(4):341-8. PubMed ID: 24035407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical antipsychotic agents ineffective for AD.
    Duke Med Health News; 2007 Jan; 13(1):8. PubMed ID: 17299888
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beware of over-interpreting negative trials.
    Scahill L; Aman MG; McCracken JT; McDougle CJ; Vitiello B
    J Autism Dev Disord; 2008 Oct; 38(9):1609-10. PubMed ID: 18594960
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of risperidone for behavioral disorders in the elderly: a clinical observation.
    Raheja RK; Bharwani I; Penetrante AE
    J Geriatr Psychiatry Neurol; 1995 Jul; 8(3):159-61. PubMed ID: 7576039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open-label, randomized, controlled trial of zotepine and risperidone for acutely ill, hospitalized, schizophrenic patients with symptoms of agitation.
    Chan HY; Lin AS; Chen KP; Cheng JS; Chen YY; Tsai CJ
    J Clin Psychopharmacol; 2013 Dec; 33(6):747-52. PubMed ID: 24100785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
    Kurz A; Schwalen S S; Schmitt A
    Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
    Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475
    [No Abstract]   [Full Text] [Related]  

  • 33. Delirium in HIV-associated dementia.
    Kapetanovic S; Simpson GM
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):767-8; reply 768-9. PubMed ID: 16832311
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
    Mowla A; Pani A
    J Clin Psychopharmacol; 2010 Feb; 30(1):40-3. PubMed ID: 20075646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic restlessness with antipsychotics.
    Bratti IM; Kane JM; Marder SR
    Am J Psychiatry; 2007 Nov; 164(11):1648-54. PubMed ID: 17974927
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolonged delirium managed with risperidone.
    Bourgeois JA; Hilty DM
    Psychosomatics; 2005; 46(1):90-1. PubMed ID: 15765831
    [No Abstract]   [Full Text] [Related]  

  • 37. Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis.
    Lin YT; Hwang TJ; Shan JC; Chiang HL; Sheu YH; Hwu HG
    J Formos Med Assoc; 2015 Feb; 114(2):147-53. PubMed ID: 25678176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of risperidone oral solution and intramuscular haloperidol with the latter shifting to oral therapy for the treatment of acute agitation in patients with schizophrenia.
    Fang M; Chen H; Li LH; Wu R; Li Y; Liu L; Ye M; Huang J; Zhu S; Wang G; Zhang Q; Zheng H; Zhang L; Wang B; Zhou J; Zhao JP
    Int Clin Psychopharmacol; 2012 Mar; 27(2):107-13. PubMed ID: 22233697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of atypical antipsychotics after traumatic brain injury.
    Elovic EP; Jasey NN; Eisenberg ME
    J Head Trauma Rehabil; 2008; 23(2):132-5. PubMed ID: 18362767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.